CNBC’s Jim Cramer took the time on Thursday to explain why he will not recommend investors to buy any cannabis or Chinese company stocks—outside of a handful of names.
The “Mad Money” host gave a number of reasons why he thinks there are a lot of risks to consider in both markets.
In the cannabis group, Cramer said he likes Canopy, Cronos, and GW Pharma, whose CEO he interviewed on Wednesday.
Out of the Chinese market, Cramer recommends buying Alibaba, a company he likened to Amazon. In addition to China’s biggest ecommerce business, he likes Baidu....More>>>